Positive Psychology Interventions in Patients with Advanced Cancer
ISRCTN | ISRCTN73517077 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN73517077 |
Secondary identifying numbers | N0544187603 |
- Submission date
- 28/09/2007
- Registration date
- 28/09/2007
- Last edited
- 02/08/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Pranathi Ramachandra
Scientific
Scientific
Palliative Care Team
Box 193
Addenbrooke's Hospital
Cambridge
CB2 2QQ
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Quality of life |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | |
Study objectives | To see if simple positive psychology interventions will improve well being and quality of life in persons with advanced cancer. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Cancer: Breast & prostate |
Intervention | Theoretical framework: psychological interventions have been known to improve quality of life, functioning, well being and immunity in early stage cancer. Similar studies are needed in late stage cancer. Purpose of the study: to see if simple, easy to use, cost effective strategies of positive psychology can be used to improve quality of life in people with advanced cancer. Study design: pilot study for a Randomised Control trial. Methodological evaluation study. Methodology: patients attending the oncology clinic at Addenbrookes Hospital will be invited to participate in the trial. An initial screening will be conducted and suitable candidates will be recruited after obtaining written consent when they come to attend their oncology clinic appointment. This is expected to take 15-30 minutes. If they agree to take part, they will be randomly allocated into one of two groups: 1. Fast-track group who will start immediately 2. A delayed start group who will start 6 weeks later The fast track group will be interviewed on the same day and asked to fill some baseline questionnaires. They will also be given written information about positive psychology methods and also verbal explanation. They will be given diary sheets to be filled out on a daily basis and tapes or CDs to listen to for their relaxation/meditation exercises. This can be done in 30-45 minutes. They will then be contacted on phone 1, 2 and 4 weeks after the first meeting in order to clarify any doubts they may have and also to encourage them to complete their daily tasks. Each phone conversation is not expected to last more than 10 minutes. After this, there will be no further phone contact. Face to face interviews will take place at 6, 12, and 18 weeks after the initial interview. Each is expected to last 30 minutes and will coincide with clinic appointments. Patients will be asked some questions and requested to fill out questionnaires at these meetings. The delayed start group will undergo an identical process, after a lag of 6 weeks. |
Intervention type | Other |
Primary outcome measure | Well being |
Secondary outcome measures | Quality of life, functioning. |
Overall study start date | 01/08/2006 |
Completion date | 01/08/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | Minimum of 10 in each group |
Key inclusion criteria | 1. Age above 18 (age of consent) 2. Women with advanced breast cancer (study involves cancer patients and breast cancer is one of the commonest forms of cancer in women) 3. Men with advanced prostate cancer (study involves cancer patients and prostate cancer is one of the commonest forms of cancer in men) |
Key exclusion criteria | 1. Significant psychological distress - it is not ethical to include them as they may benefit from treatment with medication. 2. Current treatment with medication for psychological distress, unless they have been stable on them for more than a year - inclusion of such people will confound the results of the study as it would be difficult to say whether improvement is due to medication or the intervention. 3. Those who are unable to understand, read or write in English - a currently all the material is only available in English. 4. Those who have severe memory impairment - as they may not be able to learn and use the strategies. |
Date of first enrolment | 01/08/2006 |
Date of final enrolment | 01/08/2007 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Palliative Care Team
Cambridge
CB2 2QQ
United Kingdom
CB2 2QQ
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government
Government
The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
Cambridge Consortium - Addenbrooke's (UK), Own Account NHS R&D Support Funding
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/12/2009 | Yes | No |